UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out

Cancer treatment reviews, 2019-05, Vol.75, p.39-51

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

British journal of cancer, 2013-08, Vol.109 (3), p.552-558

2013

Link zum Volltext

Verfügbarkeit prüfen

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

British journal of cancer, 2011-04, Vol.104 (8), p.1256-1261

2011

Link zum Volltext

Verfügbarkeit prüfen

Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial

Annals of oncology, 2013-12, Vol.24 (12), p.2967-2971

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeted therapy-induced diarrhea: A review of the literature

Critical reviews in oncology/hematology, 2014-05, Vol.90 (2), p.165-179

2014

Link zum Volltext

Verfügbarkeit prüfen

A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice

Medical oncology (Northwood, London, England), 2014, Vol.31 (1), p.797-797, Article 797

2014

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study

Annals of oncology, 2007-03, Vol.18 (3), p.461-467

2007

Link zum Volltext

Verfügbarkeit prüfen

Uracil ftorafur leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

British journal of cancer, 2007-02, Vol.96 (3), p.439-444

2007

Link zum Volltext

Verfügbarkeit prüfen

Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole

Endocrine-related cancer, 2004-12, Vol.11 (4), p.771-779

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease

Journal of clinical oncology, 1996-09, Vol.14 (9), p.2546-2551

1996

Link zum Volltext

Verfügbarkeit prüfen

Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism

Annals of oncology, 2002-07, Vol.13 (7), p.1059-1066

2002

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women

Journal of clinical oncology, 2005-04, Vol.23 (10), p.2155-2161

2005

Link zum Volltext

Verfügbarkeit prüfen

Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients

European journal of cancer (1990), 1999-02, Vol.35 (2), p.208-213

1999

Link zum Volltext

Verfügbarkeit prüfen

Exemestane Is Superior to Megestrol Acetate After Tamoxifen Failure in Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Randomized Double-Blind Trial

Journal of clinical oncology, 2000-04, Vol.18 (7), p.1399-1411

2000

Link zum Volltext

Verfügbarkeit prüfen

Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors

Annals of oncology, 2000-08, Vol.11 (8), p.1017-1022

2000

Link zum Volltext

Verfügbarkeit prüfen

Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer

Annals of oncology, 2003-02, Vol.14 (2), p.242-247

2003

Link zum Volltext

Verfügbarkeit prüfen

Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors

Cancer, 1999-09, Vol.86 (5), p.858-865

1999

Link zum Volltext

Verfügbarkeit prüfen

Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients

The Journal of steroid biochemistry and molecular biology, 2002-04, Vol.80 (4), p.411-418

2002

Link zum Volltext

Verfügbarkeit prüfen

The minimal effective exemestane dose for endocrine activity in advanced breast cancer

European journal of cancer (1990), 1997-04, Vol.33 (4), p.587-591

1997

Link zum Volltext

Verfügbarkeit prüfen

Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors: A study by the Italian Trials in Medical Oncology group

Cancer, 1996-01, Vol.77 (2), p.402-408

1996

Link zum Volltext

Verfügbarkeit prüfen

c-erbB 2 Serum level as prognostic factor in hormonally treated advanced breast cancer patients

Breast (Edinburgh), 2002-08, Vol.11 (4), p.286-294

2002

Link zum Volltext

Verfügbarkeit prüfen

A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: Endocrine and clinical results

Annals of oncology, 1997-07, Vol.8 (7), p.649-654

1997

Link zum Volltext

Verfügbarkeit prüfen

Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancer

European journal of cancer (1990), 1995-12, Vol.31 (13), p.2426-2427

1995

Link zum Volltext

Verfügbarkeit prüfen

A randomized, multicenter prospective trial assessing long‐acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma

Cancer, 2002-01, Vol.94 (2), p.299-304

2002

Link zum Volltext

Verfügbarkeit prüfen

Second-generation aromatase inhibitors

Tumori, 1995-03, Vol.81 (2), p.77

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Humans
(46)
Oncology
(45)
Female
(42)
Middle Aged
(35)
Aged
(34)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Pharmacology. Drug Treatments
(26)
Chemotherapy
(25)
Adult
(24)
Antineoplastic Agents
(24)
Breast Neoplasms - Drug Therapy
(22)
Aromatase Inhibitors
(18)
Male
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)
Treatment Outcome
(16)
Aged, 80 And Over
(12)
Antineoplastic Agents - Therapeutic Use
(12)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial

Targeted therapy-induced diarrhea: A review of the literature

A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice

Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study

Uracil ftorafur leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole

Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease

Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism

Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women

Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients

Exemestane Is Superior to Megestrol Acetate After Tamoxifen Failure in Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Randomized Double-Blind Trial

Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors

Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer

Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors

Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients

The minimal effective exemestane dose for endocrine activity in advanced breast cancer

Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors: A study by the Italian Trials in Medical Oncology group

c-erbB 2 Serum level as prognostic factor in hormonally treated advanced breast cancer patients

A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: Endocrine and clinical results

Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancer

A randomized, multicenter prospective trial assessing long‐acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma

Second-generation aromatase inhibitors

Aktive Filter

Suchergebnisse filtern